Viewing Study NCT00460850


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2025-12-25 @ 2:59 PM
Study NCT ID: NCT00460850
Status: TERMINATED
Last Update Posted: 2008-06-30
First Post: 2007-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module